04/07/2022 4:17 pm Welcome to isteroids.com - BLOG

Thursday 21, Jul 2016

  Chad Mendes Gets Two-Year Suspension

Posted By
Pin it Share on Tumblr

Chad Mendes, one of the world’s best featherweight fighters, has been suspended for a period of two years by the United States Anti-Doping Agency.

Mendes tested positive for a performance-enhancing drug in an out-of-competition sample May 17, according to USADA. The banned substance GHRP-6, also known as growth-hormone releasing hexapeptide, was found in the system of Mendes. The 31-year-old would not be able to make a return to the UFC until June 10, 2018, two years from the date of the beginning of his provisional suspension.

Mendes admitted he did not do his homework and remarked this was a big mistake. The UFC featherweight title contender said he owns the mistake and will pay for it.

The Team Alpha Male product has been one of the UFC’s best 145-pound fighters for the last five years. The American mixed martial artist has been disqualified from all competitive results obtained on and subsequent to May 17, 2016, the date of sample collection, including forfeiture of any title, ranking, purse or other compensation.

The #4 in official UFC featherweight rankings, Mendes is ranked the #5 featherweight in the world by Sherdog and #8 featherweight in the world by Fight Matrix. Chad Mendes twice earned NCAA All-American honors made his World Extreme Cagefighting debut against Erik Koch on March 6, 2010 at WEC 47 and his UFC debut was against judo black belt Michihiro Omigawa on February 5, 2011 at UFC 126.

The former NCAA Division I All-American wrestler last fought against Frankie Edgar at The Ultimate Fighter 22 Finale in December where Mendes suffered a knockout loss.

What Is GHRP-6?

GHRP-6 (Growth Hormone Releasing Hexapeptide) is a prohibited substance in the class of Peptide Hormones, Growth Factors, Related Substances and Mimetics under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency (WADA) Prohibited List. It belongs to the class of drugs known as growth hormone releasing peptides but it is not the same as human growth hormone (hGH). GHRP-6 is designed for improving natural production of growth hormone in the body and is commonly used by athletes and bodybuilders without requiring any “cycling” or post cycle therapy.

Growth hormone is believed to be a performance enhancing substance. Its use is associated with reductions in body fat and improvements in the levels of Insulin-like Growth Factor 1 (IGF-1) that both increases protein availability and inhibits cell death. These properties of IGF-1 facilitate significantly more efficient muscle growth & repair and aid recovery time from exercise and injury.

GHRP-6 is known to significantly increase appetite as it acts as a mimetic of ghrelin (the “hunger hormone”). It indirectly results in increased hGH production in the pituitary, primarily through ghrelin release and the hGH travels to the liver and signals it to produce IGF-1. This means many advantages for athletes such as decreased recovery times, decreased body fat, improved muscle tissue repair, and improved body composition. Growth Hormone Releasing Hexapeptide is usually injected though it may be used in cream form. Administration of GHRP-6, IGF-1 or hGH is banned by the United States Anti-Doping Agency.

pdf_iconDownload in PDF: Chad Mendes Gets Two-Year Suspension

Tuesday 12, Apr 2016

  Growth Hormones Were Given To Victorian Special Operations Group Members

Posted By
Pin it Share on Tumblr

The Melbourne Magistrates’ Court has heard that an associate of key figures in the Essendon doping scandal provided members of Victoria Police’s elite Special Operations Group with growth hormones.

The Court heard that a sergeant and his colleague from the Special Operations Group were patients of Robin James Taylor, who was charged with possessing anabolic steroids and Testosterone after his Melbourne Sport Medicine and Anti-Aging Clinic was raided in October 2013, along with a member of the Hells Angels bikies club. Taylor once used to work at Shane Charter’s doctor ageless clinic. Shane provided growth hormones and peptides to Essendon Sports scientist Stephen Dank.

The officer, who cannot be named, told the Melbourne Magistrates’ Court Taylor provided him with growth hormones SARMS 22 and GHRP 6 that help with muscle growth. The unnamed official admitted before the Court that he used the drugs to find relief from a shoulder injury. The officer said his blood test results were discussed by the controversial clinic owner and he was thereafter provided with the medication.

The officer also remarked Taylor’s co-accused doctor Hoong Pan Sze-Tho was in the room but did not speak during the consultation. The SOG member said Taylor left the room and came back with medication and added that we were shown some medication and then given some Intel on how to use that medication and the name on the packets were SARMS 22 and GHRP 6.

Taylor’s wife Georgina Matta has also been charged along with a doctor, Hoong Pan Sze-Tho, and the clinic’s receptionist, Amy Lee Gorgievski. Taylor faces more than 70 charges including trafficking other anabolic androgenic steroids, importing prohibited goods, and obtaining property by deception by purporting to be a licensed medical practitioner. Dr Sze-Tho faces 242 charges that include trafficking anabolic steroids and prescribing testosterone for other than medical treatment while Ms Matta is charged with 55 similar offences. The offences are alleged to have occurred between January 2012, and October 2013.

An audit by the Department of Health at a Chemist Warehouse pharmacist near Taylor’s Ascot Vale clinic found Dr Sze-Tho was ordering very huge amounts of testosterone that Taylor or his wife would pick up from the clinic. It was disclosed by Chris Falke, Manager of Compliance at Department of Human Services that some of the prescriptions were for 90 injections and that is an extraordinary quantity. Falke added he would say prescribing 90 injections is very difficult to justify in any circumstances.

Doping in sports is not new but rare in Australian sports. During 2013, Australia recorded 35 drugs offences, and most of these cases were from bodybuilding and Rugby (including both Union and League). Australia’s positive drug tests according to figures from the World Anti-Doping Agency were bodybuilding (seven), bowling (one), boxing (one), cycling (two), netball (one), powerlifting (four), aquatics (two cases), athletics (three), AFL (three), motorsports (one), baseball (one), rugby (six), triathlon (one), weightlifting (one) and wrestling (one). Russia had 225 drugs cases in 2013 and Turkey had a total of 188 drugs cases.

pdf_iconDownload in PDF: Growth Hormones Were Given To Victorian Special Operations Group Members

Thursday 03, Sep 2015

  Ex-Leigh And Wales Hooker Gets Doping Ban

Posted By
Pin it Share on Tumblr

UK Anti-Doping (UKAD) has announced former Leigh and Wales hooker Sean Penkywicz has been banned for two years after he tested positive for a growth hormone releasing peptide.

The 33-year-old tested positive for GHRP-6 but denied taking the substance. However, Penkywicz accepted the doping verdict and had his contract terminated by the Centurions. His sample was initially tested by the Drug Control Centre at King’s College, London and no prohibited substances were found. UK Anti-Doping instructed the laboratory on January 27 to reexamine the same sample specifically for Growth Hormone Releasing Factors. The sample was found to contain Hormone Releasing Peptide-6 (GHRP-6).

Growth Hormone Releasing Factors are classified under section S2 of the World Anti-Doping Agency’s (WADA) Prohibited List. This is the second finding of its kind in the United Kingdom for GHRP-6 that is commonly used by bodybuilders. Sean has been banned from all sport from April 9, 2015 to April 8, 2017.

In 2007, Penkywicz played for Wales in World Cup qualifiers against Scotland and Lebanon and won his last cap against England a year later. Penkywicz was in the Leigh team that won the Championship Grand Final at Headingley last October but has not played this season due to a knee injury. In 2005, he was suspended for two years after he tested positive for Stanozolol (Winstrol) after his sample tested positive for the drug following an out-of-competition test on December 5, 2014.

UKAD’s chief executive Nicole Sapstead remarked all samples taken from elite athletes can be stored for up to 10 years under the World Anti-Doping Code. She added this enables us to go back at any time and retest that same sample. Sapstead also commented that the retrospective analysis of samples, together with the Athletes Biological Passport and intelligence led testing, are all vital tools in UKAD’s mission to protect clean sport and catch those who believe they can cheat and win. The UKAD’s chief executive also remarked the message of UK Anti-Doping is clear that doping in sport will not be tolerated. She also said we will make use of every tool we can to protect clean athletes and support them to compete, and win, clean.

A few weeks back, Welsh rugby league player, Paul Songhurst, from Bridgend South Wales, was suspended from all sport for four years following an Anti-Doping Rule Violation. The 24-year-old Songhurst, who plays for South Wales Scorpions in the Kingstone Press League, tested positive for an exogenous anabolic androgenic steroid, Drostanolone, following an out-of-competition test at a club training session on 23 February 2015. Songhurst WAS banned from all competitive sport from 23 February 2015 to midnight on 22 February 2019. UKAD’s Chief Executive, Nicole Sapstead, had remarked that Paul Songhurst is the third person in the UK to receive a four year ban under the 2015 World Anti-Doping Code and we hope that this tougher sanction for a serious doping offence will deter those who may think about trying to cheat the system. Sapstead also remarked that international doping will not be tolerated at any level of sport.

pdf_iconDownload in PDF: Ex-Leigh And Wales Hooker Gets Doping Ban

Thursday 21, Aug 2014

  Cronulla Sharks Players Receive Doping Show-Cause Notices

Posted By
Pin it Share on Tumblr

Cronulla sharks players receive doping show cause notices

Show-cause notices have been issued to seventeen past and present Cronulla Sharks players over the 2011 supplements program of the club.

A proposal regarding a possible suspension by the anti-doping authority has been offered to Nathan Gardner, Wade Graham, Anthony Tupou, John Morris, and Paul Gallen.

According to News Corp Australia, the notices were distributed at a series of meetings on August 20. The players will have ten days to submit their response and have the option of challenging the notices. The Australian Sports Anti-Doping Authority (ASADA) and Cronulla have confirmed five players presently contracted to the Sharks and 12 former players of the club have received show cause notices from the Australian Sports Anti-Doping Authority.

Sharks skipper Paul Gallen is one of the involved players and expressed concern that they will be labeled as drug cheats by accepting reduced bans. Gallen remarked our reputation is tarnished now already, but no matter what, if we do this we’re going to be labeled a drug cheat. Gallen also said whatever happens is going to happen and we can just get on with life because closure on this thing would just be unbelievable after what we have gone through the past two seasons. Gallen said he had not taken any banned substance and said it would be devastating if he is prevented from playing for Australia and seeing his reputation damaged.

In a statement, the Cronulla Sharks said five players have been offered a proposal regarding a possible suspension. It was added that the Sharks will continue to act in the best interests of the players and are providing on-going support, both to those issued with the notices as well as others in the club, while solicitors acting for the players will continue to manage the process on their behalf. It was also revealed that the ASADA CEO (Ben McDevitt) based on his assessment of the evidence has reached the conclusion that the players have a case to answer under the World Anti-Doping Code.  The club statement said the Sharks will continue to act in the best interests of the players and are providing on-going support both to those issued with the notices as well as others in the club and added that solicitors acting for the players will continue to manage the process on their behalf.

In a statement, ASADA remarked the Australian Sports Anti-Doping Authority (ASADA) commenced issuing ‘show cause’ notices to current and former players from the Cronulla-Sutherland Sharks Football Club. It added a total of 17 ‘show cause’ notices are to be issued in accordance with the ASADA Chief Executive Officer’s (CEO) responsibilities under the ASADA Act and relate to the use of prohibited substances, CJC-1295 and GHRP-6, during the 2011 season and the decision to issue ‘show cause’ notices by ASADA CEO, Ben McDevitt is based on evidence collected during the 16 month investigation. ASADA added the World Anti-Doping Code’s Prohibited List categorizes CJC-1295 and GHRP-6 under S2 ‘Peptide Hormones, Growth Factors and Related Substances’ and added that anyone considering the use of these substances should be aware that they may result in potentially serious health consequences. It was added that GHRP-6 is not approved for human use in Australia.

pdf_iconDownload in PDF: Cronulla Sharks Players Receive Doping Show-Cause Notices

Friday 07, Sep 2012

  Ban For Queensland Rugby Player

Posted By
Pin it Share on Tumblr

Ban for Queensland Rugby Player

Decision of the Australian Rugby Union (ARU) to impose a four-year ban on Sunshine Coast Stingrays amateur rugby player and coach, Francis Bourke, for the possession and attempted trafficking of growth hormone releasing peptide-6 (GHRP-6) was recently acknowledged by the Australian Sports Anti-Doping Authority (ASADA).

The ban slapped on Bourke by the Rugby Union was backdated to the date of his provisional suspension, which means that he cannot participate as an athlete or support person until 25 January 2016 in any sports that have adopted a World Anti-Doping Agency compliant anti-doping policy. Such participation includes, but not limited to management, administration, playing or training as part of a team or squad, coaching, and officiating.

Bourke was found guilty of possession and attempted trafficking of growth hormone releasing peptide-6 (GHRP-6). GHRP-6 is not approved for human use in Australia and the Prohibited List of WADA Code categorizes GHRP-6 under ‘S2: peptide hormones, growth factors and related substances, and prohibited at all times. Breaching the code can invite penalties including a lifetime ban for second offences. The WADA Code has permitted sanctions of four years – even lifetime bans – under Article 10.3.2 since 2009 but this power has only rarely been imposed by WADA’s signatories.

ASADA, as a government body, works closely with the Australian Customs and Border Protection Service (Customs and Border Protection) for investigating the trafficking of prohibited drugs, medications and substances.

A package with GHRP-6 was seized at the Sydney Gateway Facility on 28 November 2010 by the Customs and Border Protection and it notified ASADA. The matter was referred to the Australian Rugby Union following an extensive investigation by ASADA as a potential violation of its anti-doping code.

The performance enhancing drug is used by budding and professional sportsmen to stimulate promote muscle, bone, and organ growth. It has the ability to stimulate the pituitary gland for secreting an increased amount of growth hormone following intake besides stimulating the protein, insulin-like growth factor 1 (known as IGF-1).

The World Anti-doping Agency  noted with interest the four-year ban on the player and WADA President John Fahey said the association has been saying for some time now that the Code sanctions are tougher than many people appreciate but they to be appropriately imposed by its signatories to make them effective. The WADA President remarked that the Australian Rugby Union (ARU) has demonstrated that it is realistic to come down hard on a person whose offense is more serious than those which usually result in a sanction of two years.

Fahey added that the ban of four years imposed on the amateur rugby player-coach also indicated that how seriously a member of an entourage, in this case a coach, will be dealt with if he or she is involved in supplying substances to athletes. Mr. Fahey added that this case is a good example of the growing efficacy of intelligence sharing between anti-doping agencies and other law enforcement authorities that have become an important pillar for the anti-doping community. He further said the World Anti-doping Agency would continue to look for ways to improve this aspect of anti-doping.

pdf_iconDownload in PDF: Ban For Queensland Rugby Player

Tuesday 10, Apr 2012


Posted By
Pin it Share on Tumblr

Hexarelin, a powerful GH-releasing peptide, is one of the most admired drugs when it comes to stimulating the release of growth hormone (GH).

Hexarelin has the chemical name of L-Histidyl-2-methyl-D-tryptophyl-L-alanyl-L-tryptophyl-D-phenylalanyl-L-lysinamide; {HIS}{D-2-ME-TRP}{ALA}{TRP}{d-PHE}{LYS}-NH2 and the molecular formula of C47H58N12O6.

The peptide, Hexarelin, is superior to GHRH and GHRP-6 in stimulating GH release and can easily stimulate the secretion of GH, ACTH (adrenocorticotropic hormone), cortisol, and prolactin during sleep. The seven-amino acid peptide is considered more effective and long lasting than GHRH (growth hormone releasing hormone) and a potent GH releasing peptide combination is experienced when Hexarelin is combined with GHRP-6 (Growth Hormone Releasing Peptide–6) compared to pairing of GHRH with GHRP-6. The combination (Hexarelin and GHRP-6) is associated with dramatic enhancements in terms of circulating IGF-1 concentrations in addition to improvements in the terms of serum IGF-1, IGF-binding protein-3 concentrations, and promotion of linear growth. Hexarelin is also beneficial in reestablishing the levels of Insulin-like development factor-I and growth hormones.

One of the biggest reasons why Hexarelin is popular among professional sportsmen is because this performance enhancing drug has the unique potential of promoting growth of new muscle fibers, increase body strength, and increase size of existing muscle fibers. In addition to these advantages, Hexarelin is also useful in promoting neural protection, joint rejuvenation, protection and healing, and fat reduction. It is also beneficial when used with growth hormone and IGF as Hexarelin restores the natural levels of hormones, such as testosterone, which may have been negatively affected by IGF and GH use.

The recommended dosage of Hexarelin is 200 mcg per day when used via subcutaneous injections and should be stored at a controlled room temperature of 20° to 25°C (68° to 77°F) to maintain its efficacy and shelf life.

Sunday 08, Apr 2012

  GHRP-6- Growth Hormone Releasing Peptide-6

Posted By
Pin it Share on Tumblr

Belonging to the category of GH secretagogues, GHRP-6 or growth hormone releasing peptide-6 is a synthetic hexapeptide that is admired for stimulating the release of growth hormone (GH) by two completely different mechanisms. While growth hormone releasing peptide-6, on one hand, amplifies the natural GHRH signal transduction pathway, it also acts as a functional antagonist of the hormone to inhibit somatostain (GH secretion).

One of the biggest reasons behind the popularity of GHRP-6 is that it has positive effects on growth hormone release and its use is closely associated with the promotion of food intake by increasing hunger. Moreover, the synthetic hexapeptide is also helpful to aid metabolism and medically recommended to help patients suffering with complications such as growth hormone deficiency, eating disorders, obesity, and cachexia.

It is also useful in promoting muscle mass and strength enhancements besides leading to loss of body fat and weight besides promoting the rejuvenation and strengthening of joints, bone mass, and connective tissue. GHRP-6 may be used for re-stimulating the natural production of growth hormone, when the natural GH secretion has been inhibited by long-term synthetic usage, as it has a direct effect on the feedback loop that signals growth hormone release inhibition. In addition to all these advantages, GHRP-6 is also useful in promoting the sense of well being, healing of joints and tendons, and improving the natural production of growth hormone, besides increasing normal pulsatile physiological secretion level by its hypothalamic action and pulsatile secretory bursts of GH.

The recommended dosage of GHRP-6 is 400-600 mcg administered via subcutaneous method, divided in 2-3 injections and it must be kept at a controlled room temperature of 25°C (77°F) with excursions permitted up to 15-30°C (59-86°F) to maintain its shelf life.

Wednesday 15, Feb 2012


Posted By
Pin it Share on Tumblr

If you want to reap the benefits of growth hormone, GHRP-6 (growth hormone releasing peptide-6) can help you in more than just a way. Classified as a peptide characterized by the release of growth hormone, GHRP6 is a synthetic hexapeptide that belongs to the category of GH secretagogues playing an important role in release of growth hormone by two completely different mechanisms.

The molecular formula of GHRP-6 is 46H56N12O6 and it has high performance liquid chromatography of 99.68 percent. It plays an all-important role in the inhibition of somatostain (GH) secretion for amplifying the natural signal transduction pathway of growth hormone releasing hormone (GHRH).

Medically, GHRP-6 is prescribed to promote improvements in normal pulsatile physiological secretion level through hypothalamic action and pulsatile secretory bursts of growth hormone. Besides this, GHRP-6 is also effective in the stimulation of hunger and intake of good besides being extremely useful to treat deficiency of growth hormone and disorders such as eating problems and obesity.

The recommended dose of GHRP6- is 400-600 mcg per week or 100 mcg per day via subcutaneous injections to boost body strength, stamina, and performance levels besides promoting the processes of fat burning and restoring the natural production of IGF-1 and GH. Growth hormone releasing peptide-6 is also considered beneficial to improve sleep patterns and the sense of well being. Use of GHRP-6 should not be made without recommendation of a qualified medical practitioner. GHRP-6 is required to be stored at a controlled room temperature of 25°C (77°F) with excursions permitted up to 15-30°C (59-86°F) for protecting its shelf life.